CCL2 and Hepatic fibrosis: The diet-induced obese hamster model displayed not only the expected metabolic comorbidities (dyslipidemia and NASH/liver fibrosis) but also a pro-inflammatory profile (with elevated serum levels of IL-6 and MCP-1) in the steady state.